Inhibiting the Mammalian Target of Rapamycin Blocks the Development of Experimental Cerebral Malaria

@inproceedings{Gordon2015InhibitingTM,
  title={Inhibiting the Mammalian Target of Rapamycin Blocks the Development of Experimental Cerebral Malaria},
  author={Emile B. Gordon and Geoffrey T. Hart and Tuan Minh Tran and Michael Waisberg and Munir Akkaya and Jeff Skinner and Severin Zin{\"o}cker and Mirna Y Pena and Takele B. Yazew and Chen-Feng Qi and Louis H. Miller and Susan K Pierce},
  booktitle={mBio},
  year={2015}
}
UNLABELLED Malaria is an infectious disease caused by parasites of several Plasmodium spp. Cerebral malaria (CM) is a common form of severe malaria resulting in nearly 700,000 deaths each year in Africa alone. At present, there is no adjunctive therapy for CM. Although the mechanisms underlying the pathogenesis of CM are incompletely understood, it is likely that both intrinsic features of the parasite and the human host's immune response contribute to disease. The kinase mammalian target of… CONTINUE READING
Highly Cited
This paper has 42 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 8 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…